C-reactive protein - Does it promote vascular disease?

Nephrology Dialysis Transplantation

Volumn 21, Issue 10, 2006, Pages 2718-2720

  Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atherosclerosis; Chronic kidney disease; CRP; Genetics; Interleukin 6

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ARTICLE; ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; DISEASE EXACERBATION; DISEASE MODEL; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HYPERTENSION; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; METABOLIC SYNDROME X; MORTALITY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE;

ANIMALS; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; HUMANS; KIDNEY DISEASES; MODELS, BIOLOGICAL; VASCULAR DISEASES;

EID: 33749597405     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl317     Document Type: Article

References (20)

1. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-126
2. Yeh ETH. CRP as a mediator of disease. Circulation 2004; 109 [Suppl II]: 11-14
3. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165-2168
4. Gill R, Kemp JA, Sabin C, Pepys MB. Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats. J Cereb Blood Flow Metab 2004; 24: 1214-1218
5. Verma S, Kuliszewski MA, Li SH et al. C-reactive protein attenuates endothelial progenitor cell survival, differentiation, and function: further evidence of a mechanistic link between C-reactive protein and cardiovascular disease. Circulation 2004; 109: 2058-2067
6. Wang CH, Li SH, Weisel RD et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation 2003; 107: 1783-1790
7. Pepys MB. CRP or not CRP? That is the question. Arterioscler Thromb Vasc Biol 2005; 25: 1091-1094
8. Paul A, Kerry WS, Li L et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 2004; 109: 647-655
9. Hirschfield GM, Gallimore JR, Kahan MC et al. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci 2005; 102: 8309-8314
10. Stenvinkel P, Ketteler M, Johnson RJ et al. Interleukin-10, IL-6 and TNF-α: Important factors in the altered cytokine network of end-stage renal disease - the good, the bad and the ugly. Kidney Int 2005; 16: 1216-1233
11. Schwedler SB, Filep JG, Galle J, Wanner C, Potempa LA. C-reactive protein: A family of proteins to regulate cardiovascular function. Am J Kidney Dis 2006; 47: 212-222
12. Pepys MB, Hirschfield GM, Tennent GA et al. Targeting C-reactive protein for the treatment of cardiovascular disease. Nature 2006; 440: 1217-1221
13. Stenvinkel P, Wanner C, Metzger TG et al. Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 2002; 62: 1791-1798
14. Menon V, Wang X, Greene T et al. Relationship between C-reactive protein, albumin, and cardiovascular disease in patients with chronic kidney disease. Am J Kidney Dis 2003; 42: 44-52
15. Pankow JS, Folsom AR, Cushman M et al. Familial and genetic determinants of systemic markers of inflammation: The NHLBI family heart study. Atherosclerosis 2001; 154: 681-689
16. Zoccali C, Testa A, Spoto B, Rtripepi G, Mallamaci F. Mendelian randomization: A new approach to studying epidemiology in ESRD. Am J Kidney Dis 2006; 47: 332-341
17. Casas JP, Shah T, Cooper J et al. Insight into the nature of the CRP-coronary event association using Mendelian randomization. Int J Epidemiol 2006; in press
18. Kardys I, de Maat MPM, Hitterlinder AG, Hofman A, Witteman JCM. C-reactive protein gene haplotypes and risk of coronary heart disease: the Rotterdam study. Eur Heart J 2006; 27: 1331-1337
19. Timpson NJ, Lawlor DA, Harbord RM et al. C-reactive protein and its role in metabolic syndrome: Mendelian randomization study. Lancet 2005; 366: 1954-1959
20. Davey SG, Lawlor DA, Harbord R et al. Association of C-reactive protein with blood pressure and hypertension: Life course confounding and Mendelian randomization tests of causality. Arterioscler Thromb Vasc Biol 2005; 25: 1051-1056